Diabetes-Docs: Physician-Scientist Career Development Program (DiabDocs)

项目摘要 我们的多中心国家K12“糖尿病-预防：医生-科学家职业生涯”的主要目标 发展计划”（Diabetes）是为了支持下一代的研究职业发展， 基础和临床糖尿病领域的医生-科学家，特别关注1型糖尿病的学术生涯 （T1D）。我们的结构化K12计划旨在提供指导研究经验， 定制的职业发展培训。鉴于医学领域代表性不足的人数比例处于历史低位 进入糖尿病研究生涯，我们建议并优先考虑有意的循证努力， 支持和资助这些人。我们提出这些目标，以实现Diabetes计划的目标： 1)创建一个由崭露头角的医生-科学家研究人员组成的国家队列，通过以下方式发展凝聚力： 分享方案培训组群的经验，包括年度务虚会; 2)扩大目前糖尿病K12项目的地理和管道覆盖范围， 候选人可以在当地接受培训，同时保持过去糖尿病K12计划的历史优势; 3)发展一个优秀的国家导师社区，以培训糖尿病医生-科学家，并提供一个 通过积极招聘，为医学生/住院医生/研究员提供更明显的研究职业途径 计划和纳入Diabetes务虚会和教育计划; 4)确保指导的一致性和有效性，包括直接关注多样性，公平性， 通过共享导师培训和资源，在研究中心之间实现包容性（DEI）。 除了我们的MPI结构，我们的程序的显着特点之一是包括所有最近- 资助的K12学者计划PI及其作为Diabetes执行领导的一部分的经验 委员会（ELC）补充增加了两名具有以下专业知识的成人内分泌科医生-科学家 基础科学，卫生服务研究和DEI计划。除了这些ELC调查员，我们还有 来自另外15个没有K12糖尿病项目的机构的不同医生-科学家参与， 对暗黑破坏神有着浓厚的兴趣这些机构带来了丰富的专业知识，包括T32，K12， P30和CTSA资金。Diabetes将利用这些资源以及他们广泛的学习课程， 研究经验，为我们的K12学者提供来自多元化教师的高质量培训。 我们预计在5年内资助55个奖学金年，每个奖学金获得者最多在K12上花费3年时间， 我们的预算平均为2年，资助27-28名学者，目标是获得独立的职业生涯 开发资金，如K 08/K23。我们的K12学者将处于有利地位，作为催化剂， 跨学科的研究将临床科学与以病人为中心的发现联系起来。我们 我们相信，我们将吸引最优秀的申请人，并指导他们走向有影响力的职业生涯， 学术医学作为熟练的医生科学家领导者。

PROJECT SUMMARY The prime objective of our multi-center National K12 “Diabetes-Docs: Physician-Scientist Career Development Program” (DiabDocs) is to support the research career development of the next generation of physician-scientists in basic and clinical diabetes for academic careers with a specific focus on type 1 diabetes (T1D). Our structured K12 program is designed to provide a mentored research experience together with tailored career development training. Given the historically low rates of persons under-represented in medicine entering diabetes research careers, we propose and prioritize here intentional evidence-based effort toward support and funding for these individuals. We propose these aims to achieve the DiabDocs program goals: 1) Create a national cohort of up-and-coming physician-scientist researchers, developing cohesion through shared programmatic training cohort experiences including an annual retreat; 2) Expand the geographical and pipeline reach of current diabetes K12 programs so that diverse K12 Scholar candidates can be trained locally while maintaining the historic strengths of the past diabetes K12 programs; 3) Develop an outstanding national mentor community to train diabetes physician-scientists and provide a more visible pathway to research careers for medical students/residents/fellows by active recruitment programs and inclusion in the DiabDocs retreat and educational programs; 4) Ensure consistency and effectiveness of mentoring, including directed attention to Diversity, Equity, and Inclusion (DEI) across research centers through shared mentor training and resources. In addition to our MPI structure, one of the distinguishing features of our program is the inclusion of all recently- funded K12 Scholar program PIs and their experience as part of the DiabDocs Executive Leadership Committee (ELC) complemented by addition of two Adult Endocrinology physician-scientists with expertise in basic science, health services research, & DEI programs. In addition to these ELC investigators, we have engaged diverse physician-scientists from 15 additional institutions without K12 programs in diabetes, but with a strong interest in engaging with DiabDocs. These institutions bring a wealth of expertise including T32, K12, P30, and CTSA funding. DiabDocs will leverage these resources as well as their wide curricula of study and research experiences to provide our K12 scholars high quality training from a diverse faculty. We anticipate funding 55 Scholar Years over 5 years with each Scholar spending up to 3 years on the K12, but we budget for 2 year terms on average with 27-28 Scholars funded with the goal to obtain independent career development funding such as a K08/K23. Our K12 scholars will be well-positioned to serve as catalysts for multidisciplinary investigations bridging bench-to-bedside science leading to patient-centered discoveries. We are confident that we will attract the highest caliber of applicants and mentor them toward impactful careers in academic medicine as skilled physician-scientist leaders.